Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Yen Lin

Showing results (191-200 of 233) with videos related to

Pageof 24
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 2015
EBV oncogene N-LMP1 induces CD4 T cell-mediated angiogenic blockade in the murine tumor modelTzong-Shoon Wu, Lian-Chen Wang, Shu-Chen Liu, et al.
The Oncologist|March 26, 2024
Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular CarcinomaChung-Wei Su, Wei Teng, Eric Yi-Liang Shen, et al.
American Journal of Cancer Research|September 11, 2023
Adding nutritional status to the original BCLC stage improves mortality prediction for hepatocellular carcinoma patients in HBV-endemic regionsYan-Ting Lin, Po-Ting Lin, Chen-Chun Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 31, 2025
Switching to tenofovir alafenamide in virally-suppressed chronic hepatitis B patients with renal/hepatic impairment: Phase 2 study sub-analysis from TaiwanChun-Jen Liu, Young-Suk Lim, Chi-Yi Chen, et al.
Human Molecular Genetics|January 19, 2018
Analysis of experience-regulated transcriptome and imprintome during critical periods of mouse visual system development reveals spatiotemporal dynamicsChi-Lin Hsu, Chih-Hsuan Chou, Shih-Chuan Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2025
Proton Beam Therapy Boosts Outcomes of Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma: A Propensity Score AnalysisYuan-Hung Kuo, Wei Teng, Po-Ting Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 12, 2018
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutionsMing-Lung Yu, Chao-Hung Hung, Yi-Hsiang Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 21, 2026
Safety, Tolerability, and Pharmacodynamics of GS-4224 in Healthy Participants and Participants With Chronic Hepatitis BEdward J Gane, Chi-Yi Chen, Cheng-Hao Tseng, et al.
Hepatology (Baltimore, Md.)|July 1, 2025
Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in hepatocellular carcinomaChien-Hao Huang, Wei-Ting Ku, Jayashri Mahalingam, et al.
The Journal of Infectious Diseases|April 9, 2019
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated SubstitutionsChung-Feng Huang, Chao-Hung Hung, Pin-Nan Cheng, et al.
Pageof 24

Showing results (191-200 of 233) with videos related to

Sort By:
Pageof 24
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 2015
EBV oncogene N-LMP1 induces CD4 T cell-mediated angiogenic blockade in the murine tumor modelTzong-Shoon Wu, Lian-Chen Wang, Shu-Chen Liu, et al.
The Oncologist|March 26, 2024
Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular CarcinomaChung-Wei Su, Wei Teng, Eric Yi-Liang Shen, et al.
American Journal of Cancer Research|September 11, 2023
Adding nutritional status to the original BCLC stage improves mortality prediction for hepatocellular carcinoma patients in HBV-endemic regionsYan-Ting Lin, Po-Ting Lin, Chen-Chun Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 31, 2025
Switching to tenofovir alafenamide in virally-suppressed chronic hepatitis B patients with renal/hepatic impairment: Phase 2 study sub-analysis from TaiwanChun-Jen Liu, Young-Suk Lim, Chi-Yi Chen, et al.
Human Molecular Genetics|January 19, 2018
Analysis of experience-regulated transcriptome and imprintome during critical periods of mouse visual system development reveals spatiotemporal dynamicsChi-Lin Hsu, Chih-Hsuan Chou, Shih-Chuan Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2025
Proton Beam Therapy Boosts Outcomes of Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma: A Propensity Score AnalysisYuan-Hung Kuo, Wei Teng, Po-Ting Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 12, 2018
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutionsMing-Lung Yu, Chao-Hung Hung, Yi-Hsiang Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 21, 2026
Safety, Tolerability, and Pharmacodynamics of GS-4224 in Healthy Participants and Participants With Chronic Hepatitis BEdward J Gane, Chi-Yi Chen, Cheng-Hao Tseng, et al.
Hepatology (Baltimore, Md.)|July 1, 2025
Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in hepatocellular carcinomaChien-Hao Huang, Wei-Ting Ku, Jayashri Mahalingam, et al.
The Journal of Infectious Diseases|April 9, 2019
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated SubstitutionsChung-Feng Huang, Chao-Hung Hung, Pin-Nan Cheng, et al.
Pageof 24